Catalyst Pharmaceuticals Inc
Catalyst Pharmaceuticals's GHG Emissions Data Preview
In 2024, Catalyst Pharmaceuticals completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Catalyst Pharmaceuticals has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy/Paste is a PRO feature.  | Copy/Paste is a PRO feature. | 0000000 |
Total Scope 2 | ||||
Location-Based | Copy/Paste is a PRO feature.  a | 0000000 | Copy/Paste is a PRO feature. | 0000000 |
Total Scope 3 | Copy/Paste is a PRO feature. | Copy/Paste is a PRO feature. | 0000000 | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 0000000 | Copy/Paste is a PRO feature. | Copy/Paste is a PRO feature. | 0000000 |
Verified Sources Behind Catalyst Pharmaceuticals’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Catalyst Pharmaceuticals’s data sources below and access millions more through our Disclosure Search.
Insights into Catalyst Pharmaceuticals's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Catalyst Pharmaceuticals amounted to 54.6 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Catalyst Pharmaceuticals's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Catalyst Pharmaceuticals's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Catalyst Pharmaceuticals were 3.6 metric tons of CO₂ equivalent (tCO₂e).a
What are Catalyst Pharmaceuticals's Scope 2 emissions?
In 2024, Catalyst Pharmaceuticals reported Scope 2 greenhouse gas (GHG) emissions of 51 tCO₂e using the location-based method.a
What methodology does Catalyst Pharmaceuticals use for Scope 2 reporting?
In 2024, Catalyst Pharmaceuticals reported its Scope 2 emissions using the location-based method.a
Catalyst Pharmaceuticals's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
Insights into Catalyst Pharmaceuticals’s GHG Emissions Intensity Compared to Industry Peers
In 2024, Catalyst Pharmaceuticals reported Scope 1 greenhouse gas (GHG) emissions of 3.6 tCO₂e and total revenues of USD 493 millions. This translates into an emissions intensity of 0.01 tCO₂e per millions USD.a
Catalyst Pharmaceuticals's Scope 1 Emissions Intensity Compared to Peers
How does Catalyst Pharmaceuticals's GHG emissions intensity compare to its peers?
In 2024, Catalyst Pharmaceuticals reported a Scope 1 emissions intensity of 0.01 tCO₂e per millions USD. Compared to the peer group median of 1.56, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
Where does Catalyst Pharmaceuticals rank on GHG emissions intensity within its industry?
In 2024, Catalyst Pharmaceuticals ranked 1 out of 22 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places Catalyst Pharmaceuticals among the top performers, with one of the lowest emissions intensities relative to peers.a